hyperCORE International, a strategic scaling platform that helps clinical research sites and organizations grow through partnership, has announced the election of its officers. Jeffrey Smyth has been elected President, Seneca Harrison as Vice President, and Claxton Copeland as Secretary, while Dustin Owen will continue serving as Treasurer. The appointments reflect hyperCORE's refreshed focus on serving two distinct audiences through one platform: clinical research site networks and contract research organizations (CROs). For site networks, hyperCORE accelerates growth while preserving independence; for CROs, it offers a single strategic connection to a growing network of experienced, high-performing research sites.
The new leadership team brings complementary expertise and strategic vision to guide hyperCORE's continued evolution, strengthen its partnerships, and support sustainable growth across the organization. In a statement, newly elected President Jeffrey Smyth expressed gratitude for the confidence placed in him by his fellow partners. "The camaraderie across our network is what makes this group special, and it positions us well for continued growth," Smyth said. "I step into this role with excitement as we scale our collective impact for CROs and patients."
Nicholas Focil, former President, emphasized the organization's core mission. "At hyperCORE, our purpose is simple. We help our partners scale," Focil said. "That means giving exceptional site networks the support to grow on their own terms, and giving CROs one trusted connection to the sites and patients their studies need. Strong leadership is essential to that mission, and we're pleased to welcome the new executive team."
hyperCORE provides established site networks with the relationships and resources to reach growth goals faster. Through shared expertise, business development, operational collaboration, and strategic partnerships, hyperCORE helps partner sites expand their reach, strengthen sponsor and CRO relationships, and build sustainable organizations. The current class of partner site networks includes Empathx Clinical Research, FOMAT Medical Research, Optimal Research Sites, QCR Network, and TrueBlue Clinical Research. Alumni include Lynd Clinical (formerly ARC), Avacare (formerly Benchmark Clinical Research), Flourish Research (formerly CSP & CTT), Centricity Research (formerly IACT Health, LMC Manna, Aventiv, and Lucas Research), and most recently, Alcanza Clinical Research.
For CROs, hyperCORE streamlines site access through a single point of contact. With one trusted relationship, CROs gain rapid feasibility with 48 to 72 hour turnaround, broader geographic reach across the United States, and expanded patient access. The network brings together more than 50 sites, 120+ principal investigators, and experience across more than 25 therapeutic areas and multiple trial phases, with access to more than 3.4 million patients. More information is available at hyperCORE International.
The election of these officers matters because it signals stability and strategic direction for an organization that occupies a unique niche in the clinical research landscape. By uniting independent site networks under a shared platform, hyperCORE enables smaller research sites to compete for complex trials that might otherwise be out of reach, while giving CROs a more efficient way to identify and engage high-quality sites. As the clinical research industry continues to globalize and trials become more complex, models that preserve site independence while delivering scale will be critical. The new leadership team will be responsible for navigating that balance, ensuring that hyperCORE's partners can grow without losing their autonomy, and that CROs continue to see the network as a reliable, high-value partner. The appointments also come at a time when patient access and trial diversity are under increasing scrutiny; hyperCORE's reach across more than 3.4 million patients and 25 therapeutic areas positions it to help address those challenges. With Smyth at the helm, the organization appears poised to build on its momentum and further solidify its role as a bridge between site networks and the sponsors and CROs that need them.
